AVEANNA HEALTHCARE HOLDINGS (AVAH) Fundamental Analysis & Valuation

NASDAQ:AVAH • US05356F1057

Current stock price

6.61 USD
-0.02 (-0.3%)
At close:
6.61 USD
0 (0%)
After Hours:

This AVAH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. AVAH Profitability Analysis

1.1 Basic Checks

  • In the past year AVAH was profitable.
  • In the past year AVAH had a positive cash flow from operations.
  • In the past 5 years AVAH reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: AVAH reported negative operating cash flow in multiple years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • The Return On Assets of AVAH (11.18%) is better than 96.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 115.29%, AVAH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 12.90%, AVAH belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AVAH is in line with the industry average of 8.74%.
  • The 3 year average ROIC (9.61%) for AVAH is below the current ROIC(12.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.18%
ROE 115.29%
ROIC 12.9%
ROA(3y)0.73%
ROA(5y)-8.3%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.61%
ROIC(5y)6.89%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K 15K

1.3 Margins

  • With an excellent Profit Margin value of 9.25%, AVAH belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 10.70%, AVAH is in the better half of the industry, outperforming 79.00% of the companies in the same industry.
  • AVAH's Operating Margin has improved in the last couple of years.
  • AVAH has a better Gross Margin (33.31%) than 66.00% of its industry peers.
  • AVAH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.7%
PM (TTM) 9.25%
GM 33.31%
OM growth 3Y79.43%
OM growth 5Y14.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y1.85%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AVAH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AVAH is creating some value.
  • Compared to 1 year ago, AVAH has more shares outstanding
  • AVAH has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AVAH has been reduced compared to a year ago.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.37, we must say that AVAH is in the distress zone and has some risk of bankruptcy.
  • AVAH's Altman-Z score of 1.37 is on the low side compared to the rest of the industry. AVAH is outperformed by 61.00% of its industry peers.
  • AVAH has a debt to FCF ratio of 12.42. This is a negative value and a sign of low solvency as AVAH would need 12.42 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 12.42, AVAH is doing worse than 60.00% of the companies in the same industry.
  • A Debt/Equity ratio of 6.62 is on the high side and indicates that AVAH has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 6.62, AVAH is doing worse than 81.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.62
Debt/FCF 12.42
Altman-Z 1.37
ROIC/WACC1.3
WACC9.94%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • AVAH has a Current Ratio of 1.32. This is a normal value and indicates that AVAH is financially healthy and should not expect problems in meeting its short term obligations.
  • AVAH's Current ratio of 1.32 is in line compared to the rest of the industry. AVAH outperforms 50.00% of its industry peers.
  • AVAH has a Quick Ratio of 1.32. This is a normal value and indicates that AVAH is financially healthy and should not expect problems in meeting its short term obligations.
  • AVAH's Quick ratio of 1.32 is in line compared to the rest of the industry. AVAH outperforms 57.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. AVAH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1100.00% over the past year.
  • AVAH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 291.49% yearly.
  • AVAH shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.19%.
  • The Revenue has been growing by 10.23% on average over the past years. This is quite good.
EPS 1Y (TTM)1100%
EPS 3Y291.49%
EPS 5YN/A
EPS Q2Q%240%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y10.82%
Revenue growth 5Y10.23%
Sales Q2Q%27.43%

3.2 Future

  • Based on estimates for the next years, AVAH will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.79% on average per year.
  • Based on estimates for the next years, AVAH will show a small growth in Revenue. The Revenue will grow by 5.47% on average per year.
EPS Next Y2.77%
EPS Next 2Y6.81%
EPS Next 3Y10.79%
EPS Next 5YN/A
Revenue Next Year5.84%
Revenue Next 2Y5.71%
Revenue Next 3Y5.47%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. AVAH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.02 indicates a reasonable valuation of AVAH.
  • Based on the Price/Earnings ratio, AVAH is valued cheaper than 91.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AVAH to the average of the S&P500 Index (26.91), we can say AVAH is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.72, the valuation of AVAH can be described as reasonable.
  • AVAH's Price/Forward Earnings ratio is rather cheap when compared to the industry. AVAH is cheaper than 89.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AVAH to the average of the S&P500 Index (23.68), we can say AVAH is valued rather cheaply.
Industry RankSector Rank
PE 11.02
Fwd PE 10.72
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AVAH is valued a bit cheaper than the industry average as 73.00% of the companies are valued more expensively.
  • AVAH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AVAH is cheaper than 79.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.66
EV/EBITDA 9.81
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AVAH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.97
PEG (5Y)N/A
EPS Next 2Y6.81%
EPS Next 3Y10.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVAH Dividend Analysis

5.1 Amount

  • AVAH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVAH Fundamentals: All Metrics, Ratios and Statistics

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (4/9/2026, 8:12:49 PM)

After market: 6.61 0 (0%)

6.61

-0.02 (-0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-19
Earnings (Next)05-06
Inst Owners32.18%
Inst Owner Change0%
Ins Owners5.99%
Ins Owner Change5.24%
Market Cap1.38B
Revenue(TTM)2.43B
Net Income(TTM)225.03M
Analysts78.82
Price Target10.26 (55.22%)
Short Float %6.61%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.62%
Min EPS beat(2)23.46%
Max EPS beat(2)51.78%
EPS beat(4)4
Avg EPS beat(4)1860.88%
Min EPS beat(4)23.46%
Max EPS beat(4)6955.89%
EPS beat(8)8
Avg EPS beat(8)1243.53%
EPS beat(12)11
Avg EPS beat(12)835.13%
EPS beat(16)11
Avg EPS beat(16)604.72%
Revenue beat(2)2
Avg Revenue beat(2)1.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)2.96%
Revenue beat(4)4
Avg Revenue beat(4)4.6%
Min Revenue beat(4)0.62%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.59%
Revenue beat(12)11
Avg Revenue beat(12)2.23%
Revenue beat(16)12
Avg Revenue beat(16)1.19%
PT rev (1m)-9.5%
PT rev (3m)-6.22%
EPS NQ rev (1m)3.64%
EPS NQ rev (3m)-5.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.4%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 11.02
Fwd PE 10.72
P/S 0.57
P/FCF 11.66
P/OCF 10.97
P/B 7.07
P/tB N/A
EV/EBITDA 9.81
EPS(TTM)0.6
EY9.08%
EPS(NY)0.62
Fwd EY9.33%
FCF(TTM)0.57
FCFY8.58%
OCF(TTM)0.6
OCFY9.11%
SpS11.65
BVpS0.93
TBVpS-4.87
PEG (NY)3.97
PEG (5Y)N/A
Graham Number3.55
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 115.29%
ROCE 16.39%
ROIC 12.9%
ROICexc 14.68%
ROICexgc 109.81%
OM 10.7%
PM (TTM) 9.25%
GM 33.31%
FCFM 4.87%
ROA(3y)0.73%
ROA(5y)-8.3%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.61%
ROIC(5y)6.89%
ROICexc(3y)10.5%
ROICexc(5y)7.44%
ROICexgc(3y)177.54%
ROICexgc(5y)164.08%
ROCE(3y)12.21%
ROCE(5y)8.75%
ROICexgc growth 3Y69.86%
ROICexgc growth 5Y0.12%
ROICexc growth 3Y97.49%
ROICexc growth 5Y26.91%
OM growth 3Y79.43%
OM growth 5Y14.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.48%
GM growth 5Y1.85%
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 6.62
Debt/FCF 12.42
Debt/EBITDA 4.77
Cap/Depr 70.65%
Cap/Sales 0.31%
Interest Coverage 1.82
Cash Conversion 46.47%
Profit Quality 52.62%
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 1.37
F-Score6
WACC9.94%
ROIC/WACC1.3
Cap/Depr(3y)57.89%
Cap/Depr(5y)61.54%
Cap/Sales(3y)0.31%
Cap/Sales(5y)0.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1100%
EPS 3Y291.49%
EPS 5YN/A
EPS Q2Q%240%
EPS Next Y2.77%
EPS Next 2Y6.81%
EPS Next 3Y10.79%
EPS Next 5YN/A
Revenue 1Y (TTM)20.19%
Revenue growth 3Y10.82%
Revenue growth 5Y10.23%
Sales Q2Q%27.43%
Revenue Next Year5.84%
Revenue Next 2Y5.71%
Revenue Next 3Y5.47%
Revenue Next 5YN/A
EBIT growth 1Y84.23%
EBIT growth 3Y98.85%
EBIT growth 5Y26.05%
EBIT Next Year8.11%
EBIT Next 3Y6.6%
EBIT Next 5YN/A
FCF growth 1Y349.93%
FCF growth 3YN/A
FCF growth 5Y3.15%
OCF growth 1Y285.63%
OCF growth 3YN/A
OCF growth 5Y1.54%

AVEANNA HEALTHCARE HOLDINGS / AVAH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AVAH.


What is the valuation status for AVAH stock?

ChartMill assigns a valuation rating of 6 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Fairly Valued.


Can you provide the profitability details for AVEANNA HEALTHCARE HOLDINGS?

AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for AVAH stock?

The Price/Earnings (PE) ratio for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 11.02 and the Price/Book (PB) ratio is 7.07.